Tracking the polyclonal neutralizing antibody response to a dengue virus serotype 1 type-specific epitope across two populations in Asia and the Americas

Dengue

(2019) Annelies Wilder-Smith et al.   LANCET

Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by NIH Monovalent Dengue Virus Vaccines

(2019) Jesica A Swanstrom et al.   JOURNAL OF INFECTIOUS DISEASES

Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate

(2018) Jesica A Swanstrom et al.   JOURNAL OF INFECTIOUS DISEASES

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes

(2018) Emily N. Gallichotte et al.   PLoS Pathogens

Reconstruction of antibody dynamics and infection histories to evaluate dengue risk

(2018) Henrik Salje et al.   NATURE

Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials

(2018) Michal Juraska et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies

(2018) Rajendra Raut et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization

(2018) Emily N. Gallichotte et al.   Cell Reports

Antigenic Characterization of a Novel Recombinant GII.P16-GII.4 Sydney Norovirus Strain With Minor Sequence Variation Leading to Antibody Escape

(2017) Lisa C Lindesmith et al.   JOURNAL OF INFECTIOUS DISEASES

Antibody-dependent enhancement of severe dengue disease in humans

(2017) Leah C. Katzelnick et al.   SCIENCE

Immune correlates of protection for dengue: State of the art and research agenda

(2017) Leah C. Katzelnick et al.   VACCINE

Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes

(2017) Daniela V. Andrade et al.   mBio

Dissecting the human serum antibody response to secondary dengue virus infections

(2017) Bhumi Patel et al.   PLoS Neglected Tropical Diseases

Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy

(2017) Maia A Rabaa et al.   eLife

Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone

(2017) Emily N. Gallichotte et al.   mSphere

Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4

(2017) Douglas G. Widman et al.   Scientific Reports

Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naïve and dengue exposed individuals

(2016) Sandra Henein et al.   JOURNAL OF INFECTIOUS DISEASES

Homotypic Dengue Virus Reinfections in Nicaraguan Children

(2016) Jesse J. Waggoner et al.   JOURNAL OF INFECTIOUS DISEASES

Evidence-based risk assessment and communication: a new global dengue-risk map for travellers and clinicians#

(2016) Emily S. Jentes et al.   JOURNAL OF TRAVEL MEDICINE

Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1

(2016) William B. Messer et al.   JOURNAL OF VIROLOGY

Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination

(2016) Usha K. Nivarthi et al.   JOURNAL OF VIROLOGY

Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort

(2016) Leah C. Katzelnick et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera

(2016) Chong-Long Chua et al.   PLoS Neglected Tropical Diseases

Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru

(2016) Brett M. Forshey et al.   PLoS Neglected Tropical Diseases

Highly divergent dengue virus type 1 genotype sets a new distance record

(2016) Alyssa T. Pyke et al.   Scientific Reports

Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection

(2015) Hannah E. Clapham et al.   JOURNAL OF INFECTIOUS DISEASES

Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers

(2015) G. Fibriansah et al.   SCIENCE

Dengue viruses cluster antigenically but not as discrete serotypes

(2015) L. C. Katzelnick et al.   SCIENCE

A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies

(2015) E. N. Gallichotte et al.   mBio

A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

(2015) Guntur Fibriansah et al.   Nature Communications

A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface

(2014) Guntur Fibriansah et al.   EMBO Molecular Medicine

Preexisting Neutralizing Antibody Responses Distinguish Clinically Inapparent and Apparent Dengue Virus Infections in a Sri Lankan Pediatric Cohort

(2014) Kizzmekia S. Corbett et al.   JOURNAL OF INFECTIOUS DISEASES

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

(2014) Wanwisa Dejnirattisai et al.   NATURE IMMUNOLOGY

Dengue Virus Neutralizing Antibody Levels Associated with Protection from Infection in Thai Cluster Studies

(2014) Darunee Buddhari et al.   PLoS Neglected Tropical Diseases

The global distribution and burden of dengue

(2013) Samir Bhatt et al.   NATURE

Worldwide Spread of Dengue Virus Type 1

(2013) Christian Julián Villabona-Arenas et al.   PLoS One

Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies

(2012) M. ŠANTAK et al.   EPIDEMIOLOGY AND INFECTION

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

(2012) Arunee Sabchareon et al.   LANCET

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

(2012) R. de Alwis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses

(2012) D. R. Burton et al.   SCIENCE

The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody

(2012) E. P. Teoh et al.   Science Translational Medicine

Development and Characterization of a Reverse Genetic System for Studying Dengue Virus Serotype 3 Strain Variation and Neutralization

(2012) William B. Messer et al.   PLoS Neglected Tropical Diseases

Evaluation of the Traditional and Revised WHO Classifications of Dengue Disease Severity

(2011) Federico Narvaez et al.   PLoS Neglected Tropical Diseases

The Nicaraguan Pediatric Dengue Cohort Study: Study Design, Methods, Use of Information Technology, and Extension to Other Infectious Diseases

(2009) G. Kuan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY